Polymedco, Inc.,/Polymedco Cancer Diagnostic Products, Llc recalls PATHFAST Myoglobin II reagent cartridge Catalog Number: PF1111-K PATHFAST¿ NTproBNP is a product for in-vitro diagnosti…
- Recall date
- April 30, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-3185-2018
- FDA classification
- Class II
- Brand / firm
- Polymedco, Inc.,/Polymedco Cancer Diagnostic Products, Llc
- Sold / distributed
- US Distribution to states of: AR, CA, FL, ID, LA, MN, NY and TX.
Why it was recalled
A pinhole caused by the laser printer in the aluminum sheet over the ALP reagent wells caused leakage through the pinhole. If the cartridge with leakage is used, higher measurement value as low as +12% and no higher than +20% bias may be obtained.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
PATHFAST Myoglobin II reagent cartridge Catalog Number: PF1111-K PATHFAST¿ NTproBNP is a product for in-vitro diagnostic use with the in vitro diagnostic system PATHFAST¿ for the quantitative measurement of N-terminal-pro B-type Natriuretic Peptide (NT-proBNP) in heparinized or EDTA whole blood and plasma.
Get recall alerts
Free email alert whenever Polymedco, Inc.,/Polymedco Cancer Diagnostic Products, Llc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Polymedco, Inc.,/Polymedco Cancer Diagnostic Products, Llc